pharmaphorum November 26, 2021

Payers are becoming savvier in accepting real-world data. Certara’s Lee Stern and Shawn Bates discuss the challenges and how pharma can use real-world data to meet payers’ needs.

For years, clinical trial data was king. But as healthcare costs continue to be squeezed, there is pressure on pharmaceutical companies to actually deliver on clinical trial efficacy in the real world. It’s no small feat in the tightly controlled and “biased” environment of randomised controlled trials. This is where a growing plethora of real-world effectiveness data comes in.

From electronic health records to medical claims information, real-world data (RWD) is increasingly being used to supplement the data generated by clinical trials. Just in September, the US...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Payer, Pharma, Pharma / Biotech
Major health insurance companies are nearing too big to fail status
Elevance Health sees double-digit profit growth in Q1, posting $2.2 B in earnings
Elevance Health posts $2.2B profit in Q1
Elevance Health Boosts Behavioral Health Biz with $740M State Contracts
Elevance's Healths new $4B primary care venture: 5 things to know

Share This Article